Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pontine tegmental cap dysplasia (PTCD) is a non-progressive neurological disorder characterized by significant developmental delay, cranial nerve dysfunction, and malformation of the hindbrain.Individuals with PTCD may have a collection of medical and developmental problems including: hearing impairment, ataxia,language and speech disorders, feeding and swallowingdifficulties, heartmalformations and facial paralysis.The severity of themedical problems varies among patients. Some patients have a good long-term prognosiswith normal intelligence and partial speech. The cause of PTCD has not been identified. Treatment is focused on managing the underlying symptoms and may include interventions such as cochlear implantation.
Features include always present findings: Overactive reflexes (hyperreflexia); and very common findings: Intellectual disability. 29 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Seizure, Ataxia, Intellectual disability |
Biomarker and diagnostic research for pontine tegmental cap dysplasia has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 1 very common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pontine tegmental cap dysplasia.
3 publications have been identified in PubMed for pontine tegmental cap dysplasia. Research spans Case Report / Case Series (67%) and Diagnostic / Biomarker (33%).
Nyila T (2025). [PMID: 41393699](https://pubmed.ncbi.nlm.nih.gov/41393699/). *Cureus*. [Case Report / Case Series]
Wang LS (2025). [PMID: 41330586](https://pubmed.ncbi.nlm.nih.gov/41330586/). *Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Diagnostic / Biomarker]
Maree M (2025). [PMID: 39868068](https://pubmed.ncbi.nlm.nih.gov/39868068/). *Radiol Case Rep*. [Case Report / Case Series]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:42 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
6 |
Strabismus, Decreased corneal sensation, Nystagmus |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Digestive system | 2 | Difficulty swallowing (dysphagia), Feeding difficulties |
Head and neck | 1 | Facial palsy |
Growth and development | 1 | Failure to thrive |
Bones and joints | 1 | Sideways curvature of the spine (scoliosis) |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |